VanEck Associates’s Tellurian Inc. TELL Stock Holding History

VanEck Associates’s Portfolio TELL Stock Details TELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,567	Closed	-$5K	–	1439
2023 Q3	$5K	Buy	4,567 +5	+0.1%	+$7	﹤0.01%	1377
2023 Q2	$6K	Buy	4,562 +1,613	+55%	+$2.17K	﹤0.01%	1377
2023 Q1	$4K	Buy	2,949 +17	+0.6%	+$27	﹤0.01%	1399
2022 Q4	$5K	Buy	+2,932	New	+$7.34K	﹤0.01%	1397

Other funds holding TELL

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VanEck Associates's TELL Position: Q4 2023 in Review

VanEck Associates sold out of Tellurian Inc. (TELL) in Q4 2023, closing a stake of 4,567 shares — an estimated $5K sold.

VanEck Associates first reported a position in TELL in Q4 2022 and held it in 4 quarters. The position peaked at $6K in Q2 2023. 235 funds tracked by Wall St. Rank hold TELL as of Q4 2023.

VanEck Associates reported no remaining Tellurian Inc. position as of Q4 2023 after selling out during the quarter.
VanEck Associates sold 4,567 Tellurian Inc. shares in Q4 2023, an estimated $5K.
VanEck Associates first reported a position in Tellurian Inc. in Q4 2022 and held it in 4 quarters.
VanEck Associates's Tellurian Inc. position peaked at $6K in Q2 2023.
235 funds tracked by Wall St. Rank held Tellurian Inc. as of Q4 2023.

Based on VanEck Associates's 13F filing for Q4 2023, filed 5 Feb 2024.